| 3D | Three-Dimensional |
| A549 | Human Lung Carcinoma Cell Line |
| AgNPs | Silver Nanoparticles |
| AI | Artificial Intelligence |
| AOPs | Adverse Outcome Pathways |
| Dbio | Biological Redox Potential Difference |
| EMA | European Medicines Agency |
| EU | European Union |
| EU-NCL | European Union Nanotechnology Characterization Laboratory |
| FDA | Food and Drug Administration |
| GD/GDs | Guidance Document/Guidance Documents |
| GLP | Good Laboratory Practice |
| GSPD | Guidance on Sample Preparation and Dosimetry |
| HE | Hydration Enthalpy |
| HepG2 | Human Liver Cancer Cell Line |
| Huh-7 | Human Hepatoma 7 Cell Line |
| IC50 | Half-Maximal Inhibitory Concentration |
| IoT | Internet of Things |
| ISO | International Organization for Standardization |
| ML | Machine Learning |
| MRI | Magnetic Resonance Imaging |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium |
| NANOMET | An EU-funded initiative supporting tailored safety testing methods for nanomaterials |
| nano-QSAR/QSAR | Quantitative Structure-Activity Relationship |
| nano-SAR | Nano-Structure-Activity Relationships |
| NMs | Nanomaterials |
| NONPs | Natural Nanoparticles |
| NPs | Engineered Nanoparticles |
| OECD | Organisation for Economic Co-operation and Development |
| OOC | Organ-on-a-Chip |
| PEG | Polyethylene glycol |
| Pk-AgNPs | Pulsatilla koreana-synthesized Silver Nanoparticles |
| QPI | Quantitative Phase Imaging |
| ROS | Reactive Oxygen Species |
| SeNPs | Selenium Nanoparticles |
| SOPs | Standard Operating Procedures |
| US-NCL | United States Nanotechnology Characterization Laboratory |
| WI-38 | Normal Human Lung Fibroblast Cell Line |